⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Molly SullivanM.D.

Hematology-Oncology · Hyannis, MA 02601

NPI: 1679679906

Share:

30

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

71

Total Claims

$1,819

Drug Cost

37

Beneficiaries

$49

Cost/Patient

Risk Score Breakdown 30/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

+551%

Opioid rate vs peers

40.8% vs 6.3% avg

-100%

Cost per patient vs peers

$49 vs $14K avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 551% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

40.8%

Opioid Rate

29

Opioid Claims

$529

Opioid Cost

Long-Acting Rate

This provider's opioid prescribing rate of 40.8% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 67 claims · $1,752

Patient Profile

73

Avg Age

51%

Female

1.84

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data